Exabis Library
Welcome to the e-CCO Library!
P216: Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P216: Does mucosal inflammation drive recurrence of PSC in liver transplant recipients with ulcerative colitis?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P216: Effect of the Crohn’s disease exclusion diet (CDED) on the fecal calprotectin level in children with active Crohn’s disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P216: Impact of disease knowledge on quality of life of inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P216: Mesenteric disease is directly related to mucosal disease in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P216: Natural course of inflammatory bowel disease in a Turkish cohort: a single tertiary centre experience in Ankara (2006–2015)
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P216: Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn's disease: a retrospective analysis of 853 consecutive patients treated in a tertiary centre.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P217 The role of 7-alfa-hydroxy-4-cholesten-3-one (C4) as a biomarker for bile acid malabsorption in inflammatory bowel disease and microscopic colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P217: Clostridium Difficile Infection as a cause of severe outcomes in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P217: Prevalence of COVID-19 in IBD patients treated with infliximab and vedolizumab in Croatian tertiary center – clinical observation of a case series
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P217: Risk factors of primary sclerosing cholangitis and cirrhosis in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P217: Serological biomarkers of type VI collagen remodelling reflect endoscopically and clinically active Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P217: The relationship between thiopurine use during pregnancy and anemia in the offspring during the first year of life
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P217: Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P217: Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P218 Linked colour imaging predicts the risk of the clinical relapse in ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P218: Accuracy of Ultrasonography in Assessing Disease Activity in Pediatric Ulcerative Colitis: Preliminary Results of a two-center study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P218: Assessment of the degree of intestinal destruction in Crohn's disease at the time of diagnosis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P218: It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P218: Oral manifestations in inflammatory bowel disease patients under anti-tumour necrosis factor treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM